There is a realistic expectation that the global effort in vaccination will bring the pandemic
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) under control …

Influenza A viruses remain a global threat to human health, with continued pandemic
potential. In this Review, we discuss our current understanding of the optimal immune …

This report updates the 2018–19 recommendations of the Advisory Committee on
Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the …

Identification of broadly neutralizing antibodies against influenza A viruses has raised hopes
for the development of monoclonal antibody–based immunotherapy and “universal” …

This report updates the 2015–16 recommendations of the Advisory Committee on
Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines (Grohskopf …

Background In the elderly, traditional influenza inactivated vaccines are often only modestly
immunogenic, owing to immunosenescence. Given that adjuvantation is a means of …

Influenza A and B virus infections are a major cause of respiratory disease in humans and
are responsible for substantial morbidity and mortality worldwide. Vaccination against …

The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of
the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was …

Influenza is a vaccine preventable disease and vaccination remains the most effective
method of controlling the morbidity and mortality of seasonal influenza, especially with …

This report updates the 2012 recommendations by CDC's Advisory Committee on
Immunization Practices (ACIP) regarding the use of influenza vaccines for the prevention …